Milos Budisavljevic, MD
Nephrology · Charleston, SCNPI 1184623654
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $869 of the $1,119 with a category attached, or 77.7%. 6 manufacturers reported payments, led by AstraZeneca at 37.7% of the total. Reporting peaked in 2019 at $351 and has fallen 75.5% since, to $86 in 2025. That places this record below the midpoint for nephrology clinicians in SC, where the typical reported total is $1,778.
Across 13 payments — averaging $86.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$422
- Sanofi$322
- Mallinckrodt Enterprises LLC$141
- Calliditas Therapeutics US Inc.$126
- Vifor Pharma, Inc.$77
- Therakos LLC$31
Across 9 payments — averaging $2655.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Enterprises LLC$13K
- Kaneka Medical America LLC$10K
- Mallinckrodt Hospital Products Inc.$1K
What the payments were for
- Speaking & faculty fees$15013%
- Food & beverage$86978%
- Education$1009%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $422 |
| Sanofi | 3 | $322 |
| Mallinckrodt Enterprises LLC | 2 | $141 |
| Calliditas Therapeutics US Inc. | 1 | $126 |
| Vifor Pharma, Inc. | 2 | $77 |
| Therakos LLC | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,119 in reported general payments places this provider in the 40th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 12 | $3,583 |
| Calcium Acetate | 18 | $1,299 |
| Amlodipine Besylate | 19 | $121 |
| Gabapentin | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Charleston
- Harold SzerlipCharleston$229K
- Joshua LipschutzCharleston$44K
- Charles BunkeCharleston$39K
- Anand AchantiCharleston$38K
- Blaithin McMahonCharleston$11K
- Michael MadaioCharleston$10K
- Roberto PisoniCharleston$7K
- Michael CaseyCharleston$5K
- Rohan KatariaCharleston$4K
- Jessica ColemanBeaufort$930K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.